You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hypercholesterolemia

Showing 1 - 25 of 1,858
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Homozygous Familial Hypercholesterolemia Trial (SHR-1918)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • (no location specified)
Aug 22, 2023

Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • NGGT006
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Nov 5, 2023

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Dyslipidemias, Children, Only Trial in Athens (Effect of Armolipid on Lipid Profile in Children With Hypercholesterolemia)

Completed
  • Dyslipidemias
  • Children, Only
  • Effect of Armolipid on Lipid Profile in Children With Hypercholesterolemia
  • Athens, Greece
    Lipid Outpatient Unit, 2nd Department of Pediatrics, Medical Sch
Sep 17, 2023

Familial Hypercholesterolemia Trial

Not yet recruiting
  • Familial Hypercholesterolemia
    • (no location specified)
    Apr 11, 2023

    Familial Hypercholesterolemia, Atherosclerosis Trial (Visualization of coronary Imaging and oral description)

    Not yet recruiting
    • Familial Hypercholesterolemia
    • Atherosclerosis
    • Visualization of coronary Imaging and oral description
    • (no location specified)
    Mar 6, 2023

    Cardiovascular Diseases, Hypercholesterolemia, Atherosclerosis Trial (PS-containing dietary supplement, Placebo)

    Not yet recruiting
    • Cardiovascular Diseases
    • +2 more
    • PS-containing dietary supplement
    • Placebo
    • (no location specified)
    Jun 2, 2023

    Familial Hypercholesterolemia Trial in Philadelphia (Cascade screening)

    Enrolling by invitation
    • Familial Hypercholesterolemia
    • Cascade screening
    • Philadelphia, Pennsylvania
      University of Pennsylvania, Perelman School of Medicine
    Feb 27, 2023

    Hypercholesterolemia Trial (HSK31679 low dose, HSK31679 medium dose, HSK31679 high dose)

    Not yet recruiting
    • Hypercholesterolemia
    • HSK31679 low dose
    • +4 more
    • (no location specified)
    Mar 20, 2023

    Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

    Not yet recruiting
    • Dyslipidemias
    • +4 more
    • Combination Therapy
    • +5 more
    • (no location specified)
    Aug 22, 2023

    Essential Hypertension, Primary Hypercholesterolemia Trial in Seoul (Fimasartan, Ezetimibe/Atorvastatin, Fimasartan Placebo)

    Not yet recruiting
    • Essential Hypertension
    • Primary Hypercholesterolemia
    • Seoul, Korea, Republic of
      Severance Hospital
    Jun 26, 2023

    Hypercholesterolemia Trial (Inclisiran, Ezetimibe, Matching Placebo for Inclisiran)

    Not yet recruiting
    • Hypercholesterolemia
    • (no location specified)
    Feb 28, 2023

    Familial Hypercholesterolemia, Cholesterol, Elevated, Genetic Disease Trial in Duluth (Motivational interview (MI))

    Recruiting
    • Familial Hypercholesterolemia
    • +2 more
    • Motivational interview (MI)
    • Duluth, Minnesota
    • +1 more
    Feb 1, 2023

    Familial Hypercholesterolemia Trial (phytosterol, krill oil, Placebo phytosterol)

    Not yet recruiting
    • Familial Hypercholesterolemia
    • phytosterol
    • +3 more
    • (no location specified)
    Jan 13, 2023

    Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe

    Not yet recruiting
    • Primary Hypercholesterolemia
    • Mixed Dyslipidemia
    • Bempedoic acid and/or its fixed dose combination with ezetimibe
    • (no location specified)
    Mar 23, 2023

    Homozygous Familial Hypercholesterolemia Trial (Evinacumab)

    Not yet recruiting
    • Homozygous Familial Hypercholesterolemia
    • (no location specified)
    Nov 3, 2022

    Familial Hypercholesterolemia Trial in Philadelphia (Testing centralized referral mechanisms for PCPs, Testing out patient

    Active, not recruiting
    • Familial Hypercholesterolemia
    • Testing centralized referral mechanisms for PCPs
    • Testing out patient outreach methods
    • Philadelphia, Pennsylvania
      University of Pennsylvania Health System
    Feb 17, 2023

    Primary Hypercholesterolemia Trial in Seoul (D377, CKD-331, D086)

    Recruiting
    • Primary Hypercholesterolemia
    • Seoul, Korea, Republic of
      Asan Medical Center
    Dec 12, 2022

    Familial Hypercholesterolemia Trial in Odense C (Biochemistry interpretive comment on elevated LDL-C levels)

    Not yet recruiting
    • Familial Hypercholesterolemia
    • Biochemistry interpretive comment on elevated LDL-C levels
    • Odense C, Denmark
      Departement of Cardiology, Odense University Hospital
    Nov 10, 2022

    Hypercholesterolemia, Dyslipidemia Trial in Seoul (Ezetimibe/Atorvastatin 10/5 mg, Atorvastatin 5mg, Ezetimibe 10mg)

    Completed
    • Hypercholesterolemia, Dyslipidemia
    • Ezetimibe/Atorvastatin 10/5 mg
    • +7 more
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Jul 24, 2023

    Familial Hypercholesterolemia Trial in Nashville (2-Hydroxybenzylamine, Placebo)

    Not yet recruiting
    • Familial Hypercholesterolemia
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Nov 4, 2022

    Hypercholesterolemia Trial in Lille (Plant food supplement, Maltodextrin)

    Completed
    • Hypercholesterolemia
    • Plant food supplement
    • Maltodextrin
    • Lille, France
      NutrINvest
    Dec 6, 2022

    Cardiovascular Risk Markers in Familial Hypercholesterolemia

    Recruiting
    • Familial Hypercholesterolemia
      • Oslo, Norway
        Oslo University Hospital
      Oct 12, 2022

      Hypercholesterolemia Trial in Japan (K-877 0.2 mg/day (once daily), K-877 0.4 mg/day (once daily), Placebo (once daily))

      Recruiting
      • Hypercholesterolemia
      • K-877 0.2 mg/day (once daily)
      • +2 more
      • Aichi, Japan
      • +14 more
      Jun 20, 2023